A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.

Saved in:
Bibliographic Details
Title: A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
Authors: Rambaldi A; Haematology, Ospedali Riuniti Di Bergamo, Largo Barozzi, Bergamo, Italy. arambaldi@ospedaliriuniti.bergamo.it, Dellacasa CM, Finazzi G, Carobbio A, Ferrari ML, Guglielmelli P, Gattoni E, Salmoiraghi S, Finazzi MC, Di Tollo S, D'Urzo C, Vannucchi AM, Barosi G, Barbui T
Source: British journal of haematology [Br J Haematol] 2010 Aug; Vol. 150 (4), pp. 446-55. Date of Electronic Publication: 2010 Jun 15.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20560970
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rambaldi+A%22">Rambaldi A</searchLink>; Haematology, Ospedali Riuniti Di Bergamo, Largo Barozzi, Bergamo, Italy. arambaldi@ospedaliriuniti.bergamo.it<br /><searchLink fieldCode="AU" term="%22Dellacasa+CM%22">Dellacasa CM</searchLink><br /><searchLink fieldCode="AU" term="%22Finazzi+G%22">Finazzi G</searchLink><br /><searchLink fieldCode="AU" term="%22Carobbio+A%22">Carobbio A</searchLink><br /><searchLink fieldCode="AU" term="%22Ferrari+ML%22">Ferrari ML</searchLink><br /><searchLink fieldCode="AU" term="%22Guglielmelli+P%22">Guglielmelli P</searchLink><br /><searchLink fieldCode="AU" term="%22Gattoni+E%22">Gattoni E</searchLink><br /><searchLink fieldCode="AU" term="%22Salmoiraghi+S%22">Salmoiraghi S</searchLink><br /><searchLink fieldCode="AU" term="%22Finazzi+MC%22">Finazzi MC</searchLink><br /><searchLink fieldCode="AU" term="%22Di+Tollo+S%22">Di Tollo S</searchLink><br /><searchLink fieldCode="AU" term="%22D'Urzo+C%22">D'Urzo C</searchLink><br /><searchLink fieldCode="AU" term="%22Vannucchi+AM%22">Vannucchi AM</searchLink><br /><searchLink fieldCode="AU" term="%22Barosi+G%22">Barosi G</searchLink><br /><searchLink fieldCode="AU" term="%22Barbui+T%22">Barbui T</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2010 Aug; Vol. 150 (4), pp. 446-55. <i>Date of Electronic Publication: </i>2010 Jun 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20560970
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/j.1365-2141.2010.08266.x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 446
    Titles:
      – TitleFull: A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rambaldi A
      – PersonEntity:
          Name:
            NameFull: Dellacasa CM
      – PersonEntity:
          Name:
            NameFull: Finazzi G
      – PersonEntity:
          Name:
            NameFull: Carobbio A
      – PersonEntity:
          Name:
            NameFull: Ferrari ML
      – PersonEntity:
          Name:
            NameFull: Guglielmelli P
      – PersonEntity:
          Name:
            NameFull: Gattoni E
      – PersonEntity:
          Name:
            NameFull: Salmoiraghi S
      – PersonEntity:
          Name:
            NameFull: Finazzi MC
      – PersonEntity:
          Name:
            NameFull: Di Tollo S
      – PersonEntity:
          Name:
            NameFull: D'Urzo C
      – PersonEntity:
          Name:
            NameFull: Vannucchi AM
      – PersonEntity:
          Name:
            NameFull: Barosi G
      – PersonEntity:
          Name:
            NameFull: Barbui T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2010 Aug
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 150
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1